An indolent case of T-prolymphocytic leukemia with t(3;22)(q21;q11.2) and elevated serum β2-microglobulin

被引:0
|
作者
Moid, F
Day, E
Schneider, MA
Goldstein, K
DePalma, L
机构
[1] George Washington Univ Hosp, Dept Pathol, Washington, DC 20037 USA
[2] George Washington Univ Hosp, Clin Labs, Washington, DC USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We report a novel case of T-prolymphocytic leukemia, small cell variant, associated with complex cytogenetic findings including t(3;22)(q21;11.2) and elevated serum beta(2)-microglobulin. The diagnosis is based on morphologic, immunophenotypic, cytogenetic, and molecular analysis of peripheral blood and bone marrow. In contrast to most reported cases of T-prolymphocytic leukemia, this patient did not present with lymphadenopathy or organomegaly. Moreover, only a moderate leukocytosis (25.3 x 10(3)/ mu L) was evident at presentation. In the absence of any specific treatment, the patient is doing well, with a stable white blood cell count 12 months following presentation. Further investigation may.be warranted to determine whether the unusual cytogenetic findings and elevated serum beta(2)-microglobulin are associated with the indolent clinical course in this patient.
引用
收藏
页码:1164 / 1167
页数:4
相关论文
共 50 条
  • [41] Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1-DTX2 chimera
    Maki, Kazuhiro
    Sasaki, Ko
    Sugita, Fusako
    Nakamura, Yuka
    Mitani, Kinuko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (02) : 268 - 273
  • [42] Translocation t(1;10)(q21;q26) in a case of acute nonlymphocytic leukemia
    Terreros, MC
    Quesada, M
    Slavutsky, IR
    ACTA HAEMATOLOGICA, 1998, 99 (02) : 92 - 94
  • [43] Der(7)t(7;8)(q34;q21) associated with t(15;17)(q22;q21): A new additional cytogenetic entity in acute promyelocytic leukemia (APL)?
    Vial, JP
    Bilhou-Nabera, C
    Mahon, FX
    Boiron, JM
    Notz, A
    Durrieu, F
    Lacombe, F
    Reiffers, J
    Praloran, V
    BLOOD, 2001, 98 (11) : 197B - 197B
  • [44] The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors
    Theil, Karl S.
    Cotta, Claudiu V.
    CANCER GENETICS, 2014, 207 (05) : 171 - 176
  • [45] Are submicroscopic chromosomal inversions predisposing factors for the t(9;22)(q34;q11.2) translocation in chronic myeloid leukemia?
    Gonzalez Garcia, Juan Ramon
    Dominguez Cruz, Martin Daniel
    Borjas Gutierrez, Cesar
    MOLECULAR CYTOGENETICS, 2015, 8
  • [46] A novel translocation t(3;22)(q21;q11) involving 3q21 in myelodysplastic syndrome-derived overt leukemia with thrombocytosis
    Yamamoto, K
    Nagata, K
    Tsurukubo, Y
    Morishita, K
    Hamaguchi, H
    LEUKEMIA RESEARCH, 2000, 24 (05) : 453 - 457
  • [47] B Lymphoblastic Leukemia (ALL) Associated with Inv(3) (q21q26)/t(3;3)(q21;q26)
    Hoehn, D.
    Chen, S. S.
    Lennon, P. A.
    Medeiros, L. J.
    Lin, P.
    MODERN PATHOLOGY, 2011, 24 : 301A - 301A
  • [48] Are submicroscopic chromosomal inversions predisposing factors for the t(9;22)(q34;q11.2) translocation in chronic myeloid leukemia?
    Juan Ramón González García
    Martín Daniel Domínguez Cruz
    César Borjas Gutiérrez
    Molecular Cytogenetics, 8
  • [49] B Lymphoblastic Leukemia (ALL) Associated with Inv(3) (q21q26)/t(3;3)(q21;q26)
    Hoehn, D.
    Chen, S. S.
    Lennon, P. A.
    Medeiros, L. J.
    Lin, P.
    LABORATORY INVESTIGATION, 2011, 91 : 301A - 301A
  • [50] Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2)
    Medeiros, Bruno C.
    Kohrt, Holbrook E.
    Arber, Daniel A.
    Bangs, Charles D.
    Cherry, Athena M.
    Majeti, Ravindra
    Kogel, Karen E.
    Azar, Catherine A.
    Patel, Samit
    Alizadeh, Ash A.
    LEUKEMIA RESEARCH, 2010, 34 (05) : 594 - 597